Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_1
1
25%
Ph phase_3
2
50%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)

Trials by Status

completed250%
not_yet_recruiting125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

NCT06532409
terminatedphase_3

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

NCT00161330
completedphase_3

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

NCT00621504
completedphase_1

Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration

NCT00493220

Clinical Trials (4)

Showing 4 of 4 trials
NCT06532409Not Applicable

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

Not Yet Recruiting
NCT00161330Phase 3

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

Terminated
NCT00621504Phase 3

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Completed
NCT00493220Phase 1

Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4